Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Steve Aselage currently holds 49,933 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steve Aselage has been a net seller of BCRX stock. They have purchased $1.0M and sold $22.5M worth of shares.
Steve Aselage's most recent insider trade was on Jun 12, 2024, when they sold 49,933 shares at $0.00 per share.
Steve Aselage serves as Executive at BIOCRYST PHARMACEUTICALS INC (BCRX). They have executed 223 insider transactions totaling $23.5M over their tenure at the company.
Steve Aselage holds the position of Executive at BIOCRYST PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Steve Aselage has shown a selling trading pattern, with $1.0M in total purchases and $22.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Steve Aselage was on Oct 7, 2021, when they sold $973.8K worth of TVTX shares. This transaction involved 60,000 shares at $16.23 per share.
Steve Aselage currently owns 49,933 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Steve Aselage's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Steve Aselage has 223 Form 4 filings on record as an insider at BIOCRYST PHARMACEUTICALS INC.
Set alerts for Steve Aselage and 40,000+ other insiders.